UA110792C2 - Pharmaceutical form bendamustine for oral use - Google Patents

Pharmaceutical form bendamustine for oral use

Info

Publication number
UA110792C2
UA110792C2 UAA201213173A UAA201213173A UA110792C2 UA 110792 C2 UA110792 C2 UA 110792C2 UA A201213173 A UAA201213173 A UA A201213173A UA A201213173 A UAA201213173 A UA A201213173A UA 110792 C2 UA110792 C2 UA 110792C2
Authority
UA
Ukraine
Prior art keywords
oral use
pharmaceutical form
pharmaceutically acceptable
bendamustine
form bendamustine
Prior art date
Application number
UAA201213173A
Other languages
Ukrainian (uk)
Inventor
Джеффрі Колледже
Марґарета Ольтофф
Original Assignee
Астеллас Дойчленд Ґмбг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астеллас Дойчленд Ґмбг filed Critical Астеллас Дойчленд Ґмбг
Priority claimed from PCT/EP2011/002764 external-priority patent/WO2011151087A1/en
Publication of UA110792C2 publication Critical patent/UA110792C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Винахід стосується фармацевтичної композиції для перорального застосування, що містить бендамустин або його фармацевтично прийнятний складний ефір, сіль або сольват у вигляді активного інгредієнта та фармацевтично прийнятний наповнювач, який є фармацевтично прийнятною неіонною гідрофільною поверхнево-активно речовиною.The invention relates to a pharmaceutical composition for oral administration containing bendamustine or its pharmaceutically acceptable ester, salt or MES in the form of the active ingredient and a pharmaceutically acceptable excipient which is a pharmaceutically acceptable non-ionic hydrophilic surfactant.

UAA201213173A 2010-06-02 2011-01-06 Pharmaceutical form bendamustine for oral use UA110792C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10075231 2010-06-02
PCT/EP2011/002764 WO2011151087A1 (en) 2010-06-02 2011-06-01 Oral dosage forms of bendamustine

Publications (1)

Publication Number Publication Date
UA110792C2 true UA110792C2 (en) 2016-02-25

Family

ID=42651316

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201213173A UA110792C2 (en) 2010-06-02 2011-01-06 Pharmaceutical form bendamustine for oral use

Country Status (1)

Country Link
UA (1) UA110792C2 (en)

Similar Documents

Publication Publication Date Title
MX2021000550A (en) Tofacitinib oral sustained release dosage forms.
MX351584B (en) Aqueous pharmaceutical formulation of tapentadol for oral administration.
EA201491285A1 (en) IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID
MX2013014788A (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]am ino]-n-5-(4-methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids.
CY1118032T1 (en) PROCESSES FOR COMMERCIAL PREPARATION OF PHARMACEUTICAL ACTIVE AGENT
UA106636C2 (en) MORPHOLINOTIAZOLES AS A POSITIVE ALLOSTERIC ALPHA MODULATORS 7
MX348823B (en) Stable formulations of linaclotide.
EA201491479A1 (en) DERIVATIVES OF LUPANOV TRITERPENOIDS AND THEIR PHARMACEUTICAL APPLICATIONS
MX2011005643A (en) Oral dosage forms of bendamustine.
JO3587B1 (en) Oral dosage forms of bendamustine
TN2015000135A1 (en) Modified release formulations for oprozomib
EA201691490A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING BRINZOLAMIDE
EP2796450A4 (en) 6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis
WO2012085284A3 (en) High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
WO2012085249A3 (en) Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
GR1008228B (en) Pharmaceutical composition comprising a dual reuptake inhibitor and method for the preparation thereof
TR201803451T4 (en) OLMESARTAN FORMULATIONS.
UA110792C2 (en) Pharmaceutical form bendamustine for oral use
IN2014CN04119A (en)
IN2012CH05549A (en)
EP2842938A4 (en) Novel beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient
WO2012153347A3 (en) Oral pharmaceutical composition of olanzapine form 1 and sodium starch glycolate
WO2011161223A3 (en) Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
EP3010534A4 (en) Pharmaceutical formulations and methods for oral delivery of biologically active ingredient
EA201500366A1 (en) APPLICATION OF 1-ADAMANTYLETYLOXY-3-MORFOLINO-2-PROPANOL OR ITS PHARMACEUTICALLY ADOPTABLE SALTS IN PHARMACEUTICAL COMPOSITIONS AS A NEURORTHINOPROTECTOR